Evidence-Based Complementary and Alternative Medicine

Copyright © 2013 Matthew J. Rabito and Alan David Kaye. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

1. National Center for Complementary and Alternative Medicine, December 2012, http://nccam.nih.gov.
2. P. M. Barnes, B. Bloom, and R. L. Nahin, “Complementary and alternative medicine use among adults and children: United States, 2007,” National Health Statistics Reports 12, National Center for Health Statistics, Hyattsville, Md, USA, 2008. View at Google Scholar
3. M. Frass, R. P. Strassl, H. Friehs, M. Mullner, M. Kundi, and A. D. Kaye, “Use and acceptance of complementary and alternative medicine among the general population and medical personnel: a systematic review,” The Ochsner Journal, vol. 12, pp. 45–56, 2012. View at Google Scholar
4. Heart Disease, Centers for Disease Control and Prevention, December 2012, http://www.cdc.gov/heartdisease/facts.htm.
5. G. Y. Yeh, R. B. Davis, and R. S. Phillips, “Use of complementary therapies in patients with cardiovascular disease,” American Journal of Cardiology, vol. 98, no. 5, pp. 673–680, 2006. View at Publisher · View at Google Scholar · View at Scopus
6. S. J. Grant, Y. S. Bin, H. Kiat, and D. H. T. Chang, “The use of complementary and alternative medicine by people with cardiovascular disease: a systematic review,” BMC Public Health, vol. 12, article 299, 2012. View at Publisher · View at Google Scholar
7. E. C. Rizos, E. E. Ntzani, E. Bika, M. S. Kostapanos, and M. S. Elisaf, “Association between Omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis,” The Journal of the American Medical Association, vol. 308, no. 10, pp. 1024–1033, 2012. View at Google Scholar
8. H. T. Ong and J. S. Cheah, “Statin alternatives or just placebo: an objective review of omega-3, red yeast rice and garlic in cardiovascular therapeutics,” Chinese Medical Journal, vol. 121, no. 16, pp. 1588–1594, 2008. View at Google Scholar · View at Scopus
9. S. N. Stabler, A. M. Tejani, F. Huynh, and C. Fowkes, “Garlic for the prevention of cardiovascular morbidity and mortality in hypertensive patients.,” Cochrane Database of Systematic Reviews, no. 8, Article ID CD007653, 2012. View at Publisher · View at Google Scholar
10. K. M. Reinhart, C. I. Coleman, C. Teevan, P. Vachhani, and C. M. White, “Effects of garlic on blood pressure in patients with and without systolic hypertension: a meta-analysis,” Annals of Pharmacotherapy, vol. 42, no. 12, pp. 1766–1771, 2008. View at Publisher · View at Google Scholar · View at Scopus
11. K. Ried, O. R. Frank, N. P. Stocks, P. Fakler, and T. Sullivan, “Effect of garlic on blood pressure: a systematic review and meta-analysis,” BMC Cardiovascular Disorders, vol. 8, article 13, 2008. View at Publisher · View at Google Scholar · View at Scopus
12. M. Karmazyn, M. Moey, and X. T. Gan, “Therapeutic potential of ginseng in the management of cardiovascular disorders,” Drugs, vol. 71, no. 15, pp. 1989–2008, 2011. View at Publisher · View at Google Scholar
13. B. J. Park, Y. J. Lee, H. R. Lee et al., “Effects of Korean red ginseng on cardiovascular risks in subjects with metabolic syndrome: a Double-Blind Randomized Controlled Study,” Korean Journal of Family Medicine, vol. 33, pp. 190–196, 2012. View at Publisher · View at Google Scholar
14. S. Kim, B. C. Shin, M. S. Lee, H. Lee, and E. Ernst, “Red ginseng for type 2 diabetes mellitus: a systematic review of randomized controlled trials,” Chinese Journal of Integrative Medicine, vol. 17, no. 12, pp. 937–944, 2011. View at Google Scholar
15. T. E. Brinkley, J. F. Lovato, A. M. Arnold et al., “Effect of ginkgo biloba on blood pressure and incidence of hypertension in elderly men and women,” American Journal of Hypertension, vol. 23, no. 5, pp. 528–533, 2010. View at Publisher · View at Google Scholar · View at Scopus
16. L. H. Kuller, D. G. Ives, A. L. Fitzpatrick et al., “Does ginkgo biloba reduce the risk of cardiovascular events?” Circulation, vol. 3, no. 1, pp. 41–47, 2010. View at Publisher · View at Google Scholar · View at Scopus
17. R. Guo, M. H. Pittler, and E. Ernst, “Hawthorn extract for treating chronic heart failure,” Cochrane Database of Systematic Reviews, no. 1, Article ID CD005312, 2008. View at Google Scholar · View at Scopus
18. E. Koch and F. A. Malek, “Standardized extracts from hawthorn leaves and flowers in the treatment of cardiovascular disorders preclinical and clinical studies,” Planta Medica, vol. 77, no. 11, pp. 1123–1128, 2011. View at Publisher · View at Google Scholar · View at Scopus
19. M. Tassell, R. Kingston, D. Gilroy, M. Lehane, and A. Furey, “Hawthorn (Crataegus spp.) in the treatment of cardiovascular disease,” Pharmacognosy Reviews, vol. 4, no. 7, pp. 32–41, 2010. View at Publisher · View at Google Scholar · View at Scopus
20. A. Pan, D. Yu, W. Demark-Wahnefried, O. H. Franco, and X. Lin, “Meta-analysis of the effects of flaxseed interventions on blood lipids,” American Journal of Clinical Nutrition, vol. 90, no. 2, pp. 288–297, 2009. View at Publisher · View at Google Scholar · View at Scopus
21. D. Rodriguez-Leyva, C. M. C. Bassett, R. McCullough, and G. N. Pierce, “The cardiovascular effects of flaxseed and its omega-3 fatty acid, alpha-linolenic acid,” Canadian Journal of Cardiology, vol. 26, no. 9, pp. 489–496, 2010. View at Google Scholar · View at Scopus
22. J. Peterson, J. Dwyer, H. Adlercreutz, A. Scalbert, P. Jacques, and M. L. McCullough, “Dietary lignans: physiology and potential for cardiovascular disease risk reduction,” Nutrition Reviews, vol. 68, no. 10, pp. 571–603, 2010. View at Publisher · View at Google Scholar · View at Scopus
23. K. Prasad, “Flaxseed and cardiovascular health,” Journal of Cardiovascular Pharmacology, vol. 54, no. 5, pp. 369–377, 2009. View at Publisher · View at Google Scholar · View at Scopus
24. G. Bjelakovic, D. Nikolova, L. L. Gluud, R. G. Simonetti, and C. Gluud, “Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases,” Cochrane Database of Systematic Reviews, no. 2, Article ID CD007176, 2008. View at Google Scholar · View at Scopus
25. H. D. Sesso, J. E. Buring, W. G. Christen et al., “Vitamins E and C in the prevention of cardiovascular disease in men: The Physicians' Health Study II randomized controlled trial,” The Journal of the American Medical Association, vol. 300, no. 18, pp. 2123–2133, 2008. View at Publisher · View at Google Scholar · View at Scopus
26. I. M. Lee, N. R. Cook, J. M. Gaziano et al., “Vitamin E in the primary prevention of cardiovascular disease and cancer. The women's health study: a randomized controlled trial,” The Journal of the American Medical Association, vol. 294, no. 1, pp. 56–65, 2005. View at Publisher · View at Google Scholar · View at Scopus
27. N. R. Cook, C. M. Albert, J. M. Gaziano et al., “A randomized factorial trial of vitamins C and E and beta carotene in the secondary prevention of cardiovascular events in women: results from the Women's Antioxidant Cardiovascular Study,” Archives of Internal Medicine, vol. 167, no. 15, pp. 1610–1618, 2007. View at Publisher · View at Google Scholar · View at Scopus
28. S. R. Steinhubl, “Why have antioxidants failed in clinical trials?” American Journal of Cardiology, vol. 101, no. 10, pp. S14–S19, 2008. View at Publisher · View at Google Scholar · View at Scopus
29. M. Klimek, S. Wang, and A. Ogunkanmi, “Safety and efficacy of red yeast rice (Monascus purpureus) as an alternative therapy for hyperlipidemia,” P & T, vol. 34, no. 6, pp. 313–327, 2009. View at Google Scholar · View at Scopus
30. D. J. Becker, R. Y. Gordon, S. C. Halbert, B. French, P. B. Morris, and D. J. Rader, “Red yeast rice for dyslipidemia in statin-intolerant patients: a randomized trial,” Annals of Internal Medicine, vol. 150, no. 12, pp. 830–839, 2009. View at Google Scholar · View at Scopus
31. R. Y. Gordon and D. J. Becker, “The role of red yeast rice for the physician,” Current Atherosclerosis Reports, vol. 13, no. 1, pp. 73–80, 2011. View at Publisher · View at Google Scholar · View at Scopus
32. R. Y. Gordon, T. Cooperman, W. Obermeyer, and D. J. Becker, “Marked variability of monacolin levels in commercial red yeast rice products: buyer beware!,” Archives of Internal Medicine, vol. 170, no. 19, pp. 1722–1727, 2010. View at Publisher · View at Google Scholar · View at Scopus
33. F. M. Sacks, A. Lichtenstein, L. Van Horn, W. Harris, P. Kris-Etherton, and M. Winston, “Soy protein, isoflavones, and cardiovascular health: an American Heart Association Science Advisory for professionals from the Nutrition Committee,” Circulation, vol. 113, no. 7, pp. 1034–1044, 2006. View at Publisher · View at Google Scholar · View at Scopus
34. K. L. Miller, R. S. Liebowitz, and L. K. Newby, “Complementary and alternative medicine in cardiovascular disease: a review of biologically based approaches,” American Heart Journal, vol. 147, no. 3, pp. 401–411, 2004. View at Publisher · View at Google Scholar · View at Scopus
35. C. Mingorance, R. Rodríguez-Rodríguez, M. L. Justo, M. Alvarez de Sotomayor, and M. D. Herrera, “Critical update for the clinical use of L-carnitine analogs in cardiometabolic disorders,” Vascular Health and Risk Management, vol. 7, pp. 169–176, 2011. View at Google Scholar · View at Scopus
36. H. Kiat and Y. S. Bin, “Prevalence of dietary supplement use in patients with proven or suspected cardiovascular disease,” Evidence-Based Complementary and Alternative Medicine, vol. 2011, Article ID 632829, 12 pages, 2011. View at Publisher · View at Google Scholar · View at Scopus
37. A. Tachjian, V. Maria, and A. Jahangir, “Use of herbal products and potential interactions in patients with cardiovascular diseases,” Journal of the American College of Cardiology, vol. 55, no. 6, pp. 515–525, 2010. View at Publisher · View at Google Scholar · View at Scopus
38. H. O. Dickinson, F. Campbell, F. R. Beyer et al., “Relaxation therapies for the management of primary hypertension in adults: a Cochrane review,” Journal of Human Hypertension, vol. 22, no. 12, pp. 809–820, 2008. View at Publisher · View at Google Scholar · View at Scopus
39. J. A. Dusek, P. L. Hibberd, B. Buczynski et al., “Stress management versus lifestyle modification on systolic hypertension and medication elimination: a randomized trial,” Journal of Alternative and Complementary Medicine, vol. 14, no. 2, pp. 129–138, 2008. View at Publisher · View at Google Scholar · View at Scopus
40. A. Casey, B. H. Chang, J. Huddleston, N. Virani, H. Benson, and J. A. Dusek, “A model for integrating a mind/body approach to cardiac rehabilitation: outcomes and correlators,” Journal of Cardiopulmonary Rehabilitation and Prevention, vol. 29, no. 4, pp. 230–238, 2009. View at Publisher · View at Google Scholar · View at Scopus
41. R. Nahas, “Complementary and alternative medicine approaches to blood pressure reduction: an evidence-based review,” Canadian Family Physician, vol. 54, no. 11, pp. 1529–1533, 2008. View at Google Scholar · View at Scopus
42. R. H. Schneider, K. G. Walton, J. W. Salerno, and S. I. Nidich, “Cardiovascular disease prevention and health promotion with the transcendental meditation program and Maharishi Consciousness-Based Health Care,” Ethnicity and Disease, vol. 16, supplement 4, no. 3, pp. 15–26, 2006. View at Google Scholar · View at Scopus
43. M. B. Ospina, K. Bond, M. Karkhaneh et al., “Clinical trials of meditation practices in health care: characteristics and quality,” Journal of Alternative and Complementary Medicine, vol. 14, no. 10, pp. 1199–1213, 2008. View at Publisher · View at Google Scholar · View at Scopus
44. T. Field, “Yoga clinical research review,” Complementary Therapies in Clinical Practice, vol. 17, no. 1, pp. 1–8, 2011. View at Publisher · View at Google Scholar · View at Scopus
45. A. Ross and S. Thomas, “The health benefits of yoga and exercise: a review of comparison studies,” Journal of Alternative and Complementary Medicine, vol. 16, no. 1, pp. 3–12, 2010. View at Publisher · View at Google Scholar · View at Scopus
46. G. Y. Yeh, C. Wang, P. M. Wayne, and R. S. Phillips, “The effect of Tai chi exercise on blood pressure: a systematic review,” Preventive Cardiology, vol. 11, no. 2, pp. 82–89, 2008. View at Publisher · View at Google Scholar · View at Scopus
47. C. Wang, J. P. Collet, and J. Lau, “The effect of Tai chi on health outcomes in patients with chronic conditions: a systematic review,” Archives of Internal Medicine, vol. 164, no. 5, pp. 493–501, 2004. View at Publisher · View at Google Scholar · View at Scopus
48. G. Y. Yeh, E. P. McCarthy, P. M. Wayne et al., “Tai chi exercise in patients with chronic heart failure: a randomized clinical trial,” Archives of Internal Medicine, vol. 171, no. 8, pp. 750–757, 2011. View at Publisher · View at Google Scholar · View at Scopus
49. A. D. Kaye, A. J. Kaye, J. Swinford et al., “The effect of deep-tissue massage therapy on blood pressure and heart rate,” Journal of Alternative and Complementary Medicine, vol. 14, no. 2, pp. 125–128, 2008. View at Publisher · View at Google Scholar · View at Scopus
50. A. Moraska, R. A. Pollini, K. Boulanger, M. Z. Brooks, and L. Teitlebaum, “Physiological adjustments to stress measures following massage therapy: a review of the literature,” Evidence-Based Complementary and Alternative Medicine, vol. 7, no. 4, pp. 409–418, 2010. View at Publisher · View at Google Scholar · View at Scopus
51. K. Mangum, L. Partna, and D. Vavrek, “Spinal manipulation for the treatment of hypertension: a systematic qualitative literature review,” Journal of Manipulative and Physiological Therapeutics, vol. 35, pp. 235–243, 2012. View at Publisher · View at Google Scholar
52. H. Lee, S. Y. Kim, J. Park, Y. J. Kim, H. Lee, and H. J. Park, “Acupuncture for lowering blood pressure: systematic review and meta-analysis,” American Journal of Hypertension, vol. 22, no. 1, pp. 122–128, 2009. View at Publisher · View at Google Scholar · View at Scopus
53. S. H. Cho, J. S. Lee, L. Thabane, and J. Lee, “Acupuncture for obesity: a systematic review and meta-analysis,” International Journal of Obesity, vol. 33, no. 2, pp. 183–196, 2009. View at Publisher · View at Google Scholar · View at Scopus
54. F. Liang and D. Koya, “Acupuncture: is it effective for treatment of insulin resistance?” Diabetes, Obesity and Metabolism, vol. 12, no. 7, pp. 555–569, 2010. View at Publisher · View at Google Scholar · View at Scopus
55. J. G. Anderson and A. G. Taylor, “Biofield therapies in cardiovascular disease management: a brief review,” Holistic Nursing Practice, vol. 25, no. 4, pp. 199–204, 2011. View at Publisher · View at Google Scholar · View at Scopus
56. J. A. Rindfleisch, “Biofield therapies: anergy medicine and primary care,” Primary Care, vol. 37, no. 1, pp. 165–179, 2010. View at Publisher · View at Google Scholar · View at Scopus
57. R. S. C. Friedman, M. M. Burg, P. Miles, F. Lee, and R. Lampert, “Effects of Reiki on autonomic activity early after acute coronary syndrome,” Journal of the American College of Cardiology, vol. 56, no. 12, pp. 995–996, 2010. View at Publisher · View at Google Scholar · View at Scopus
58. B. MacIntyre, J. Hamilton, T. Fricke, W. Ma, S. Mehle, and M. Michel, “The efficacy of healing touch in coronary artery bypass surgery recovery: a randomized clinical trial,” Alternative Therapies in Health and Medicine, vol. 14, no. 4, pp. 24–32, 2008. View at Google Scholar · View at Scopus